196 related articles for article (PubMed ID: 19004863)
1. Determining the cost of genital warts: a study from Ireland.
Dee A; Howell F; O'Connor C; Cremin S; Hunter K
Sex Transm Infect; 2009 Sep; 85(5):402-3. PubMed ID: 19004863
[TBL] [Abstract][Full Text] [Related]
2. [Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France].
Monsonégo J; Breugelmans JG; Bouée S; Lafuma A; Bénard S; Rémy V
Gynecol Obstet Fertil; 2007 Feb; 35(2):107-13. PubMed ID: 17270482
[TBL] [Abstract][Full Text] [Related]
3. Assessing incidence and economic burden of genital warts with data from a US commercially insured population.
Hoy T; Singhal PK; Willey VJ; Insinga RP
Curr Med Res Opin; 2009 Oct; 25(10):2343-51. PubMed ID: 19650749
[TBL] [Abstract][Full Text] [Related]
4. Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom.
Woodhall SC; Jit M; Cai C; Ramsey T; Zia S; Crouch S; Birks Y; Newton R; Edmunds WJ; Lacey CJ
Sex Transm Dis; 2009 Aug; 36(8):515-21. PubMed ID: 19543143
[TBL] [Abstract][Full Text] [Related]
5. Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.
Östensson E; Fröberg M; Leval A; Hellström AC; Bäcklund M; Zethraeus N; Andersson S
PLoS One; 2015; 10(9):e0139062. PubMed ID: 26398189
[TBL] [Abstract][Full Text] [Related]
6. Medical Care Costs Associated with Genital Warts for Commercially Insured US Patients.
Dahlstrom KR; Fu S; Chan W; Shelal Z; Ramondetta LM; Lairson DR
Pharmacoeconomics; 2018 Nov; 36(11):1355-1365. PubMed ID: 30019118
[TBL] [Abstract][Full Text] [Related]
7. Estimation of the impact of genital warts on health-related quality of life.
Woodhall S; Ramsey T; Cai C; Crouch S; Jit M; Birks Y; Edmunds WJ; Newton R; Lacey CJ
Sex Transm Infect; 2008 Jun; 84(3):161-6. PubMed ID: 18339658
[TBL] [Abstract][Full Text] [Related]
8. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.
Oliphant J; Perkins N
N Z Med J; 2011 Jul; 124(1339):51-8. PubMed ID: 21952330
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and cost of treatment of genital warts in Spain.
Castellsagué X; Cohet C; Puig-Tintoré LM; Acebes LO; Salinas J; San Martin M; Breitscheidel L; Rémy V
Eur J Public Health; 2009 Jan; 19(1):106-10. PubMed ID: 19112075
[TBL] [Abstract][Full Text] [Related]
10. [Genital warts and HPV vaccination].
Pilka R; Dvorák V; Fait T
Ceska Gynekol; 2011 Dec; 76(6):468-70. PubMed ID: 22312844
[TBL] [Abstract][Full Text] [Related]
11. The costs of treating external genital warts in England and Wales: a treatment pattern analysis.
Langley PC; White DJ; Drake SM
Int J STD AIDS; 2004 Aug; 15(8):501-8. PubMed ID: 15307958
[TBL] [Abstract][Full Text] [Related]
12. The new human papillomavirus (HPV) vaccine: pros and cons for pediatric and adolescent health.
Thomas TL
Pediatr Nurs; 2008; 34(5):429-31. PubMed ID: 19051848
[TBL] [Abstract][Full Text] [Related]
13. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
Syrjänen KJ
Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and costs associated with genital warts in Canada.
Marra F; Ogilvie G; Colley L; Kliewer E; Marra CA
Sex Transm Infect; 2009 Apr; 85(2):111-5. PubMed ID: 18981170
[TBL] [Abstract][Full Text] [Related]
15. [Quality of life of patients with condyloma].
Mortensen GL; Larsen HK
Ugeskr Laeger; 2008 Nov; 170(47):3858-62. PubMed ID: 19014739
[TBL] [Abstract][Full Text] [Related]
16. Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study.
Hillemanns P; Breugelmans JG; Gieseking F; Bénard S; Lamure E; Littlewood KJ; Petry KU
BMC Infect Dis; 2008 Jun; 8():76. PubMed ID: 18518976
[TBL] [Abstract][Full Text] [Related]
17. Cost-benefit analysis on the HPV vaccine in Medicaid-enrolled females of the Appalachian region of Kentucky.
Prasad SR; Hill R
J Ky Med Assoc; 2008 Jun; 106(6):271-6. PubMed ID: 18630037
[TBL] [Abstract][Full Text] [Related]
18. Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium.
Annemans L; Rémy V; Lamure E; Spaepen E; Lamotte M; Muchada JP; Largeron N
J Med Econ; 2008; 11(1):135-50. PubMed ID: 19450115
[TBL] [Abstract][Full Text] [Related]
19. The health and economic burden of genital warts in a set of private health plans in the United States.
Insinga RP; Dasbach EJ; Myers ER
Clin Infect Dis; 2003 Jun; 36(11):1397-403. PubMed ID: 12766834
[TBL] [Abstract][Full Text] [Related]
20. The incidence of genital warts in Australian women prior to the national vaccination program.
Brotherton JM; Heywood A; Heley S
Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]